*j, SSS.SSS.SSS./SSS.SSS.SS S.S S S./SS S.SS S.SSS./SSS.SSS.SSS./SSS.SSS.SSS./SSS.SSS.SSS./SSS.SSS.SSS./SSS.SSS.SSS./S.rg) zClinical pathszXIntravenous rehydration may be used when oral rehydration is not feasible or has failed.)titlecontent DiagnosiszUOral rehydration therapy is the first-line approach in [[273|acute gastroenteritis]]. ManagementznEarly refeeding should be initiated as part of management of childhood gastroenteritis, following rehydration.a**[[368|Hypocalcemia]]** - Infants are screened for [[368|hypocalcemia]] when low birthweight, born to diabetic mothers, asphyxiated, affected by DiGeorge syndrome, or born to mothers with hyperparathyroidism **Pyridoxine Dependency** - [[315|Seizures]] resistant to standard anticonvulsants are recognized as a clinical clue - Pyridoxine dependency is considered in infants with intrauterine convulsionsa**Hypoglycemia** - Blood glucose is assessed urgently in at-risk infants (intrauterine growth restriction, infants of diabetic mothers) **Hypocalcemia** - Serum magnesium is assessed concurrently, as hypomagnesemia frequently accompanies hypocalcemia **[[170|Hyponatremia]]** - Fluid management practices are reviewed - Syndrome of inappropriate antidiuretic hormone secretion is evaluated for **Hypernatremia** - Feeding adequacy in breastfed infants is assessed - Correct formula dilution in formula-fed infants is verifieda**Hypoglycemia** - Early treatment initiation is critical to prevent [[315|seizures]] **Hypocalcemia** - Magnesium deficiency is corrected to facilitate calcium correction **Hyponatremia** - Fluid intake and osmolarity are adjusted as indicated **Hypernatremia** - Underlying [[99|dehydration]] is addressed **Pyridoxine Dependency** - Specific treatment with pyridoxine may be indicated based on clinical suspicion and diagnostic confirmationzPrognosis and outcomezv**Hypoglycemia** - Duration of [[321|hypoglycemia]] and time to treatment are key determinants of neurological outcomez**Incidental Hypertension** Initial steps include: - Pain control - Measures to calm the patient - Serial blood pressure monitoringa**Diagnostic Approach** 1. Blood pressure is measured by auscultation (not oscillatory devices) using an appropriately sized cuff for the patient's arm circumference 2. Elevation is confirmed at three separate visits before hypertension is diagnosed 3. In athletes with persistently elevated BP: - Family history of hypertension is asked about - Use of stimulants (caffeine, nicotine, ephedrine) or anabolic steroids is asked about - In those <25 years with upper extremity hypertension, lower extremity BP is checked to exclude coarctation of the aorta 4. 24-hour ambulatory blood pressure monitoring is considered to exclude white coat hypertensiona0**Treatment** Target blood pressure: less than the 90th percentile for sex, age, and height, or less than 130/80 mm Hg, whichever is lower. First-line approach: nutritional changes proven to treat hypertension. Pharmacological treatment is considered for those not responding to lifestyle modification.a**Initial assessment and airway management:** If the infant cries at birth and establishes regular respiration, no resuscitation is required. If respiration is not established, initiating lung inflation within the first minute of life is the priority. For infants born through meconium-stained fluid: - **Vigorous infants** (normal respiratory effort, heart rate, and tone): Routine tracheal suctioning is not recommended - **Non-vigorous infants** (decreased respiratory effort, heart rate, or tone): Direct tracheal suctioning is reasonable if meconium is present at delivery - Attempting to aspirate meconium from the nose and mouth while the infant's head is on the perineum is not recommended, as it is ineffective - If the infant becomes bradycardic, positive pressure ventilation to aerate the lungs is indicated despite the presence of meconium - If the baby was born through thick meconium, it is reasonable to inspect the oropharynx rapidly and remove any thick meconium by suctioning with a large-bore suction catheteru**Extubation criteria** include: - Peak inspiratory pressure of 12–14 cm H₂O (larger babies may be extubated with PIP 14) - Respiratory rate of 20–25 breaths per minute - FiO₂ requirement less than 40%a:**Ongoing respiratory support:** Mechanical ventilation is often required. Extubation to nasal CPAP or non-invasive positive pressure ventilation is especially useful in very low birth weight babies. Postextubation management includes periodic suctioning as needed, gentle chest physiotherapy, and nebulization with ipratropium to aid stabilization. **Advanced support:** High-frequency oscillatory ventilation and inhaled nitric oxide may be considered for infants with persistent pulmonary hypertension of the newborn who do not respond to conventional management.a**Screening and Identification** Screening for mental health concerns should be systematic and occur at multiple touchpoints: - Preparticipation physical evaluations - Every routine medical encounter - When concerning behaviors are observed during athletic participation or other activities **Recognition of Risk** Alertness is maintained to factors that may indicate mental health risk: - Performance-related stress (particularly in athletes) - Pressure to meet expectations from family, coaches, or peers - Recent injury or illness - Identity-related concerns - Social isolation or limited support networks - Behavioral changes during participation in activitiesz**Assessment Setting** Private, one-on-one discussion time between the young person and the healthcare provider is ensured. This is particularly important during telehealth visits to allow confidential assessment away from family members or others.a'**Management Considerations** When mental health concerns are identified, consideration is given to: - Referral to mental health specialists where available - Integration of care with primary care providers - Involvement of family and support systems - Recognition that emergency department and emergency medical services may be utilized when specialist access is limited Note: The passages provided do not contain specific medication dosing, psychotherapy protocols, or detailed treatment algorithms suitable for inclusion in this clinical section.aX**Initial Evaluation** - A detailed history including exposure history, incubation period considerations, and symptom timeline is obtained - A thorough physical examination documenting clinical manifestations is performed - Risk factors including immunocompromised status, underlying chronic conditions, or group care attendance are identifiedz**Diagnostic Approach** - Pathogen-specific diagnostic tests are ordered based on clinical presentation and suspected organism - Incubation period is considered in timing of diagnostic testing - Findings are documented to guide organism identificationar**Treatment Considerations** - Antimicrobial therapy is selected based on identified or suspected organism - Age-appropriate dosing is used and route of administration is specified - Supportive care is provided, tailored to the infection type and severity - Complications and treatment response are monitored for **Special Populations** - Children with congenital heart disease or other chronic conditions may require modified prevention and treatment approaches - Immunocompromised hosts warrant specialized management strategies - Consultation with pediatric infectious disease specialists is considered for complex casesu**Identification and Management During Outbreaks** When vaccine-preventable diseases are suspected or confirmed: 1. **Identify vaccination status** — Whether the child has been fully vaccinated according to the recommended childhood and adolescent vaccination schedule is determined 2. **Protect vulnerable contacts** — Very young infants and immunocompromised children who have had contact with the case are identified, as these populations are at especially high risk for serious disease and cannot be completely immunizedu**Household contact assessment** — Parents and close family contacts are evaluated for their vaccination status, as evidence suggests children are frequently exposed to pathogens through household transmission from inadequately protected adultsu**Outbreak response** — During outbreaks of vaccine-preventable diseases, unvaccinated or undervaccinated children should be removed from schools and other congregate settings **Note:** The reference passages do not provide specific clinical management protocols, diagnostic criteria, or treatment regimens for individual vaccine-preventable diseases. Disease-specific chapters should be consulted for clinical details.z**Initial Assessment** Symptoms are assessed for: altered consciousness, poor feeding, apnea, cyanosis, hypothermia, hypotonia, tremor, or [[315|seizures]].a**Initial Assessment** [[321|hypoglycemia]] is confirmed: capillary glucose screening below 40 mg/dL is verified by laboratory serum or plasma glucose measurement. In any sick infant, critical blood and urine samples are collected before treatment is started, to guide diagnosis.u**Treatment Approach** **For asymptomatic or mildly symptomatic infants:** - Early enteral feeding is initiated with human milk or standard infant formula (30–60 mL per feed) - Expected glucose rise: 20–30 mg/dL within the first hour - Frequent feeding is continued to maintain glucose homeostasis **For symptomatic hypoglycemia or failure of enteral feeding:** - Rapid intravenous correction is provided - 10% dextrose (D10W) is used intravenously - Treatment continues until normal glucose homeostasis is established and adequate substrate supply is secured **Monitoring and Targets** - First 48 hours: blood glucose is maintained >50 mg/dL - After 48 hours: blood glucose is maintained >60 mg/dL if intravenous glucose is required - Once blood glucose is stabilized, normal feedings resume - Infants unable to maintain preprandial glucose >50 mg/dL by 48 hours or >60 mg/dL after 48 hours require investigation for persistent [[321|hypoglycemia]] before discharge **Special Considerations** - Breastfed newborns have lower blood glucose and higher ketone concentrations compared to formula-fed infants - Suspected congenital hyperinsulinism requires genetic analysis and may require diazoxide or other medications for long-term control)Z[\]^_`aN)PARTSh/tmp/claude-0/-home-danvics-docker-quiz/c1e0577a-e42c-4a3d-b1ea-3edd61103a4e/scratchpad/mdm/b01_part2.pyrs (FG "}~ $XY (RS  #A B  $q r "/ijE$N (&' #de $fg!0  (t u #&' $FG6 (;< #ef $uv)@ (}~ #>?  $` a4 (wx #_` $wx  (IJ #DE $IJIC r